Related Experiment Video
Updated: Jun 11, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Clot prevention--common questions about medications
1Department of Clinical Pharmacology, The Royal Adelaide Hospital, South Australia. rami.tadros@health.sa.gov.au
Australian Family Physician
|July 15, 2010
Summary
Managing warfarin therapy presents challenges. Routine genetic testing is not recommended, and new oral anticoagulants are not yet approved as warfarin substitutes in Australia.
Area of Science:
- Pharmacology
- Clinical Medicine
- Patient Management
Background:
- Warfarin is a widely prescribed anticoagulant.
- Managing warfarin therapy can be complex for clinicians.
- Several clinical questions arise regarding its optimal use.
Purpose of the Study:
- To address common clinical questions concerning warfarin.
- To provide guidance on warfarin management.
- To review current evidence and recommendations.
Main Methods:
- Literature review of clinical guidelines and studies.
- Discussion of evidence-based practices.
- Synthesis of information on warfarin use.
Main Results:
- Routine genetic testing prior to warfarin initiation is not advised.
- New oral anticoagulants are not yet available in Australia for long-term warfarin substitution.
- Strategies for preventing air travel-related thrombosis are presented.
Conclusions:
- Current evidence does not support routine genetic testing for warfarin.
- The landscape of oral anticoagulants is evolving, with limited long-term warfarin substitutes in Australia.
- Proactive measures are necessary to mitigate risks associated with warfarin, including thrombosis during air travel and bleeding events.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...